Oxygenta Pharmaceutical Ltd (524636) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524636 | NSE: | Pharmaceuticals & Drugs | Small Cap

Oxygenta Pharma Share Price

60 0.45 0.76%
as on 05-Dec'25 12:07

Oxygenta Pharmaceutical Ltd (524636) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524636 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Oxygenta Pharma

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Oxygenta Pharmaceutical stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
220.2 Cr.
52-wk low:
53.6
52-wk high:
133.5

Is Oxygenta Pharmaceutical Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Oxygenta Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Oxygenta Pharmaceutical Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%0%0%0%0%3.2%-50.3%-41.7%-25.6%-
Value Creation
Index
NANANANANANANANANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 12.48.212.920.513.75260.53139.6109112
Sales YoY Gr.--34.4%57.9%59.4%-33.1%279.2%16.3%-48.8%27.9%175.7%-
Adj EPS -5.4-5.7-4.4-3.2-8.42.9-0-7.8-1.1-2.6-4.6
YoY Gr.-NANANANANA-101.1%NANANA-
BVPS (₹) -21.1-26.8-31.3-34.5-40.1-37.3-24.4-32.5-6.2-6.8-9.8
Adj Net
Profit
-5.5-5.8-4.5-3.3-8.62.9-0-11.1-3.5-9.4-17
Cash Flow from Ops. 0.90.51.3-7.8-2.6-1.6-1.7-1.6-13.12.6-
Debt/CF from Ops. 20.63714.9-2.9-10.4-29.5-31-41.6-4.423.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 27.3%51.4%21.8%175.7%
Adj EPS NANANANA
BVPSNANANANA
Share Price 24.7% 52.4% 30.5% -36.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
29.223.715.39.722.5-7.40.127.410.641.756.1
Op. Profit
Mgn %
-33.5-59.4-31.1-10-57.47.42.4-23-24.4-8.8-15.6
Net Profit
Mgn %
-44.3-71.2-35.2-15.9-62.55.6-0.1-35.7-8.9-8.6-15.3
Debt to
Equity
-0.8-0.7-0.6-0.6-0.7-1.3-1.5-1.5-2.8-2.5-
Working Cap
Days
19429015112221682822172359696
Cash Conv.
Cycle
-247-229-154-75-14-11-05226-2-140

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Oxygenta Pharmaceutical Ltd.

Standalone Consolidated
TTM EPS (₹) -4.6 -
TTM Sales (₹ Cr.) 112 -
BVPS (₹.) -9.8 -
Reserves (₹ Cr.) -73 -
P/BV -6.11 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 53.56 / 133.50
All Time Low / High (₹) 0.10 / 133.50
Market Cap (₹ Cr.) 220
Equity (₹ Cr.) 37
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Oxygenta Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Oxygenta Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Oxygenta Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales12813211452613140109
Operating Expenses 171317232248593849119
Manufacturing Costs33322697712
Material Costs861016163747243496
Employee Cost 3333241667
Other Costs 2211122223
Operating Profit -4-5-4-2-841-7-10-10
Operating Profit Margin (%) -33.5%-59.4%-31.1%-10.0%-57.4%7.4%2.4%-23.0%-24.5%-8.9%
Other Income 0110000001
Interest 1111121122
Depreciation 1111112231
Exceptional Items 0000421-10-0
Profit Before Tax -6-6-4-3-63-0-11-14-12
Tax -000-0-0000-10-2
Profit After Tax -5-6-5-3-63-1-12-3-10
PAT Margin (%) -44.3%-71.2%-35.2%-15.9%-42.2%5.6%-1.0%-37.3%-8.8%-8.9%
Adjusted EPS (₹)-5.4-5.7-4.4-3.2-5.72.9-0.4-8.2-1.0-2.6
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund -22-27-32-35-41-38-35-46-21-25
Share Capital 10101010101014143337
Reserves -32-38-42-45-51-48-49-60-54-62
Minority Interest0000000000
Debt17181821264852675661
Long Term Debt17181821254551624922
Short Term Debt00000315740
Trade Payables1591198146242330
Others Liabilities 10192026261079-46
Total Liabilities 20191721193431545473

Fixed Assets

Gross Block23232425253136465161
Accumulated Depreciation10111213141516192122
Net Fixed Assets 13121212111620282940
CWIP 0000010000
Investments 0000000000
Inventories12254127121421
Trade Receivables11010221075
Cash Equivalents 0000000000
Others Assets 4333232447
Total Assets 20191721193431545473

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 111-8-3-2-2-2-133
PBT -6-6-4-3-63-0-11-14-12
Adjustment 1122233442
Changes in Working Capital 554-61-8-46-312
Tax Paid 0-0-000-0-000-0
Cash Flow From Investing Activity -2-1-0-1-0-7-5-10-4-11
Capex -2-1-0-1-1-7-50-4-11
Net Investments 0000000000
Others 0000000-1000
Cash Flow From Financing Activity 10-1839611179
Net Proceeds from Shares 00000040295
Net Proceeds from Borrowing 2109410313-11-27
Interest Paid -1-1-1-1-1-2-1-1-2-2
Dividend Paid 0000000000
Others -000-00-000132
Net Cash Flow -00-0000-0-0-00

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
ROCE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Asset Turnover Ratio0.660.420.711.080.691.981.860.730.731.72
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A-0.67N/AN/AN/AN/A
Working Capital Days
Receivable Days315319912710698121
Inventory Days21634961128575811211757
Payable Days58479036822420010978230254100

Oxygenta Pharmaceutical Ltd Stock News

Oxygenta Pharmaceutical Ltd FAQs

The current trading price of Oxygenta Pharma on 05-Dec-2025 12:07 is ₹60.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Oxygenta Pharma stood at ₹220.2.
The latest P/E ratio of Oxygenta Pharma as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Oxygenta Pharma as of 04-Dec-2025 is -6.11.
The 52-week high of Oxygenta Pharma is ₹133.5 and the 52-week low is ₹53.56.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Oxygenta Pharma is ₹112.1 ( Cr.) .

About Oxygenta Pharmaceutical Ltd

SS Organics was incorporated in 1990, is a pharmaceutical company involved in the manufacture and marketing of bulk drugs and intermediates.

A wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs are manufactured. The product range also includes omeprazole, rabeprazole sodium, lansoprazole, esomeprazole magnesium trihydrate, non-pariel seeds, pantoprazole pellets, diclofenac sodium pellets, gabapentior, mooxafloxacin, ramipril, atorvastatin, and voriconazole.

Designed and built as per US FDA standards for production of bulk drugs and custom synthesis of intermediates, the plant located in the Medak district of Andhra Pradesh has an installed capacity 320 TPA. Major export destinations include Europe, USA, South America, and Asia Pacific Region. It reaches the America markets through its subsidiary based in Maryland, USA.

The registered office is at Survey No 252/1, Aroor Village, Sadasivapet Mandal, Medak, Andhra Pradesh.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×